Oncology Research Hub

Explore cutting-edge studies in tumor biology, molecular pathways, and clinical breakthroughs

Research Articles

The Cellular Double Agent: How a "Junk" RNA Holds the Key to New Cancer Therapies

Discover how NEAT1, once considered junk RNA, and its regulator HIF-2 are revolutionizing cancer treatment approaches through cellular proliferation and apoptosis regulation.

Julian Foster
Oct 20, 2025

Popular Articles

Research Tags